Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35

Xin Liu, Iona Cheng, Sarah J. Plummer, Brian K. Suarez, Graham Casey, William J. Catalona, John S. Witte

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


BACKGROUND. Deciphering the genetic basis of prostate cancer aggressiveness could provide valuable information for the screening and treatment of this common but complex disease. We previously detected linkage between a broad region on chromosome 7q22-35 and Gleason score - a strong predictor of prostate cancer aggressiveness. To further clarify this finding and focus on the potentially causative gene, we undertook a fine-mapping study across the 7q22-35 region. METHODS. Our study population encompassed 698 siblings diagnosed with prostate cancer. 3,072 single nucleotide polymorphisms (SNPs) spanning the chromosome 7q22-35 region were genotyped using the Illumina GoldenGate assay. The impact of SNPs on Gleason scores were evaluated using affected sibling pair linkage and family-based association tests. RESULTS. We confirmed the previous linkage signal and narrowed the 7q22-35 prostate cancer aggressiveness locus to a 370 kb region. Centered under the linkage peak is the gene KLRG2 (killer cell lectin-like receptor subfamily G, member 2). Association tests indicated that the potentially functional non-synonymous SNP rs17160911 in KLRG2 was significantly associated with Gleason score (P=0.0007). CONCLUSIONS. These findings suggest that genetic variants in the gene KLRG2 may affect Gleason score at diagnosis and hence the aggressiveness of prostate cancer.

Original languageEnglish (US)
Pages (from-to)682-689
Number of pages8
Issue number7
StatePublished - May 15 2011


  • Gleason score
  • Prostate cancer
  • SNP
  • Siblings

ASJC Scopus subject areas

  • Oncology
  • Urology


Dive into the research topics of 'Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35'. Together they form a unique fingerprint.

Cite this